Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine significantly reduces levels of HIV RNA and HIV DNA rebound following ART interruption in a phase I/II randomized controlled clinical trial

Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine significantly reduces levels of HIV RNA and HIV DNA rebound following ART interruption in a phase I/II randomized controlled clinical trial

Bibliographic Details
Main Authors: Erwann P. Loret, Albert Darque, Elvenn A. Loret, Corinne Nicolino-Brunet, Sophie Morange, Elisabeth Castagnier, Josiane Casanova, Christine Caloustian, Charléric Bornet, Julie Coussirou, Jihen Bousseta, Bertrand Dussol, Isabelle Ravaux
Format: Article
Language:English
Published: Elsevier 2016-05-01
Series:Journal of Virus Eradication
Online Access:http://www.sciencedirect.com/science/article/pii/S2055664020311857
id doaj-2f6cc72f06ae4c6cac69dcac1af79c5c
record_format Article
spelling doaj-2f6cc72f06ae4c6cac69dcac1af79c5c2021-05-04T07:24:50ZengElsevierJournal of Virus Eradication2055-66402016-05-01239Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine significantly reduces levels of HIV RNA and HIV DNA rebound following ART interruption in a phase I/II randomized controlled clinical trialErwann P. Loret0Albert Darque1Elvenn A. Loret2Corinne Nicolino-Brunet3Sophie Morange4Elisabeth Castagnier5Josiane Casanova6Christine Caloustian7Charléric Bornet8Julie Coussirou9Jihen Bousseta10Bertrand Dussol11Isabelle Ravaux12ETRAV Laboratory CNRS/AMU, Marseille, FranceETRAV Laboratory CNRS/AMU, Marseille, France; La Conception University Hospital, Dispensary, Marseille, FranceETRAV Laboratory CNRS/AMU, Marseille, FranceETRAV Laboratory CNRS/AMU, Marseille, FranceClinical Investigation Center, La Conception University Hospital, Marseille, FranceClinical Investigation Center, La Conception University Hospital, Marseille, FranceClinical Investigation Center, La Conception University Hospital, Marseille, FranceClinical Investigation Center, La Conception University Hospital, Marseille, FranceLa Conception University Hospital, Dispensary, Marseille, FranceLa Conception University Hospital, Dispensary, Marseille, FranceLa Conception University Hospital, Dispensary, Marseille, FranceClinical Investigation Center, La Conception University Hospital, Marseille, FranceETRAV Laboratory CNRS/AMU, Marseille, Francehttp://www.sciencedirect.com/science/article/pii/S2055664020311857
collection DOAJ
language English
format Article
sources DOAJ
author Erwann P. Loret
Albert Darque
Elvenn A. Loret
Corinne Nicolino-Brunet
Sophie Morange
Elisabeth Castagnier
Josiane Casanova
Christine Caloustian
Charléric Bornet
Julie Coussirou
Jihen Bousseta
Bertrand Dussol
Isabelle Ravaux
spellingShingle Erwann P. Loret
Albert Darque
Elvenn A. Loret
Corinne Nicolino-Brunet
Sophie Morange
Elisabeth Castagnier
Josiane Casanova
Christine Caloustian
Charléric Bornet
Julie Coussirou
Jihen Bousseta
Bertrand Dussol
Isabelle Ravaux
Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine significantly reduces levels of HIV RNA and HIV DNA rebound following ART interruption in a phase I/II randomized controlled clinical trial
Journal of Virus Eradication
author_facet Erwann P. Loret
Albert Darque
Elvenn A. Loret
Corinne Nicolino-Brunet
Sophie Morange
Elisabeth Castagnier
Josiane Casanova
Christine Caloustian
Charléric Bornet
Julie Coussirou
Jihen Bousseta
Bertrand Dussol
Isabelle Ravaux
author_sort Erwann P. Loret
title Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine significantly reduces levels of HIV RNA and HIV DNA rebound following ART interruption in a phase I/II randomized controlled clinical trial
title_short Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine significantly reduces levels of HIV RNA and HIV DNA rebound following ART interruption in a phase I/II randomized controlled clinical trial
title_full Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine significantly reduces levels of HIV RNA and HIV DNA rebound following ART interruption in a phase I/II randomized controlled clinical trial
title_fullStr Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine significantly reduces levels of HIV RNA and HIV DNA rebound following ART interruption in a phase I/II randomized controlled clinical trial
title_full_unstemmed Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine significantly reduces levels of HIV RNA and HIV DNA rebound following ART interruption in a phase I/II randomized controlled clinical trial
title_sort intradermal injection of a tat oyi-based therapeutic hiv vaccine significantly reduces levels of hiv rna and hiv dna rebound following art interruption in a phase i/ii randomized controlled clinical trial
publisher Elsevier
series Journal of Virus Eradication
issn 2055-6640
publishDate 2016-05-01
url http://www.sciencedirect.com/science/article/pii/S2055664020311857
work_keys_str_mv AT erwannploret intradermalinjectionofatatoyibasedtherapeutichivvaccinesignificantlyreduceslevelsofhivrnaandhivdnareboundfollowingartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial
AT albertdarque intradermalinjectionofatatoyibasedtherapeutichivvaccinesignificantlyreduceslevelsofhivrnaandhivdnareboundfollowingartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial
AT elvennaloret intradermalinjectionofatatoyibasedtherapeutichivvaccinesignificantlyreduceslevelsofhivrnaandhivdnareboundfollowingartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial
AT corinnenicolinobrunet intradermalinjectionofatatoyibasedtherapeutichivvaccinesignificantlyreduceslevelsofhivrnaandhivdnareboundfollowingartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial
AT sophiemorange intradermalinjectionofatatoyibasedtherapeutichivvaccinesignificantlyreduceslevelsofhivrnaandhivdnareboundfollowingartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial
AT elisabethcastagnier intradermalinjectionofatatoyibasedtherapeutichivvaccinesignificantlyreduceslevelsofhivrnaandhivdnareboundfollowingartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial
AT josianecasanova intradermalinjectionofatatoyibasedtherapeutichivvaccinesignificantlyreduceslevelsofhivrnaandhivdnareboundfollowingartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial
AT christinecaloustian intradermalinjectionofatatoyibasedtherapeutichivvaccinesignificantlyreduceslevelsofhivrnaandhivdnareboundfollowingartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial
AT charlericbornet intradermalinjectionofatatoyibasedtherapeutichivvaccinesignificantlyreduceslevelsofhivrnaandhivdnareboundfollowingartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial
AT juliecoussirou intradermalinjectionofatatoyibasedtherapeutichivvaccinesignificantlyreduceslevelsofhivrnaandhivdnareboundfollowingartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial
AT jihenbousseta intradermalinjectionofatatoyibasedtherapeutichivvaccinesignificantlyreduceslevelsofhivrnaandhivdnareboundfollowingartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial
AT bertranddussol intradermalinjectionofatatoyibasedtherapeutichivvaccinesignificantlyreduceslevelsofhivrnaandhivdnareboundfollowingartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial
AT isabelleravaux intradermalinjectionofatatoyibasedtherapeutichivvaccinesignificantlyreduceslevelsofhivrnaandhivdnareboundfollowingartinterruptioninaphaseiiirandomizedcontrolledclinicaltrial
_version_ 1721479890330451968

Similar Items